REMODULIN Side Effects

6862192-4 | Device Related Infection, Kidney Infection, Syncope
on Jul 06, 2010 Female patient from UNITED STATES , 33 years of age, weighting 185.2 lb, was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: device related infection, kidney infection, syncope. Remodulin dosage: 38.88 Ug/kg (0.027 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6862189-4 | Catheterisation Cardiac, Pericardial Effusion, Pneumothorax, Procedural Complication
Patient was taking Remodulin (View Usage). Patient had the following side effects: catheterisation cardiac, pericardial effusion, pneumothorax, procedural complication on Jul 08, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 249.1 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 64.8 Ug/kg (0.045 Ug/kg, 1 In 1min), Intravenous. During the same period patient was treated with VITAMIN B COMPLEX (B KOMPLEX) (View Vitamin B Complex (b-komplex) Review and Vitamin B Complex (b-komplex) Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), EVISTA (View Evista Review and Evista Label ), REQUIP XL (View Requip Xl Review and Requip Xl Label ). Patient was hospitalized.

6862187-0 | Anxiety, Ascites, Fatigue, Hypertension, Nervousness, Oedema, Right Ventricular Failure, Sluggishness, Tachycardia
Adverse event was reported on Jul 08, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 115.2 Ug/kg (0.08 Ug/kg, 1 In 1 Min), Intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 66 years of age, weighting 190.0 lb, After Remodulin was administered, patient had the following side effects: anxiety (What is anxiety?), ascites, fatigue, hypertension, nervousness, oedema, right ventricular failure, sluggishness, tachycardia. During the same period patient was treated with REVATIO (120 Mg, (40 Mg, 3 In 1 D)) (View Revatio Review and Revatio Label ), AMBRISENTAN (AMBRISENTAN) (View Ambrisentan (ambrisentan) Review and Ambrisentan (ambrisentan) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LASIX (View Lasix Review and Lasix Label ), PREMARIN (View Premarin Review and Premarin Label ), NEXIUM (View Nexium Review and Nexium Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ), CLARITIN (View Claritin Review and Claritin Label ).

6847589-0 | Pericardial Effusion
on Jun 29, 2010 Female patient from UNITED STATES , 48 years of age, was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: pericardial effusion. Remodulin dosage: 50.4 Ug/kg (0.035 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.


6847583-X | Epistaxis, Oxygen Saturation Decreased, Pneumonia
on Jun 30, 2010 Female patient from UNITED STATES , 68 years of age, weighting 169.8 lb, was treated with Remodulin (View Usage). Patient had the following side effects: epistaxis, oxygen saturation decreased, pneumonia (What is pneumonia?). Remodulin dosage: 152.64 Ug/kg (0.106 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VIAGRA (View Viagra Review and Viagra Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6847582-8 | Disease Progression, Dyspnoea, Infusion Site Erythema, Infusion Site Haemorrhage, Infusion Site Infection, Infusion Site Pain, Pulmonary Hypertension
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: disease progression, dyspnoea, infusion site erythema, infusion site haemorrhage, infusion site infection, infusion site pain, pulmonary hypertension (What is pulmonary hypertension?) on Jul 01, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: Subcutaneous. Patient was hospitalized.

6829691-2 | Abscess, Infection, Pain In Extremity, Poor Personal Hygiene, Swelling, Treatment Noncompliance
Adverse event was reported on Jun 18, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: Subcutaneous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), infection (What is infection?), pain in extremity, poor personal hygiene, swelling, treatment noncompliance. During the same period patient was treated with KLOR CON (View Klor-con Review and Klor-con Label ), ISOSORB MON (ISOSORBIDE DINITRATE) (View Isosorb Mon (isosorbide Dinitrate) Review and Isosorb Mon (isosorbide Dinitrate) Label ), LEOVTHYROXIN (LEVOTHYROXIN) (View Leovthyroxin (levothyroxin) Review and Leovthyroxin (levothyroxin) Label ), PROVIGIL (MONAFINIL) (View Provigil (monafinil) Review and Provigil (monafinil) Label ), MAGNEBIND (GALENIC /MAGNESIUM CRAB/CALCIUM CARD/) (View Magnebind (galenic /magnesium Crab/calcium Card/) Review and Magnebind (galenic /magnesium Crab/calcium Card/) Label ). Patient was hospitalized.

6829685-7 | Antibiotic Resistant Staphylococcus Test Positive, Chest Pain, Device Related Infection, Jugular Vein Thrombosis
on Jun 22, 2010 Female patient from UNITED STATES , 52 years of age, weighting 235.5 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: antibiotic resistant staphylococcus test positive, chest pain (What is chest pain?), device related infection, jugular vein thrombosis. Remodulin dosage: 13.32 Ug/kg (0.00925 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ), REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6829684-5 | Pneumonia
on Jun 22, 2010 Female patient from UNITED STATES , 76 years of age, was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: pneumonia (What is pneumonia?). Remodulin dosage: 60.48 Ug/kg (0.42 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PRINIVIL (LISINIOPRIL) (View Prinivil (lisiniopril) Review and Prinivil (lisiniopril) Label ), IMDUR (View Imdur Review and Imdur Label ), PLAVIX (View Plavix Review and Plavix Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), MUCINEX (View Mucinex Review and Mucinex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6829683-3 | Ammonia Increased, Bronchitis, Diarrhoea, Gastric Haemorrhage, Haematemesis, Hepatic Function Abnormal, Nausea
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: ammonia increased, bronchitis (What is bronchitis?), diarrhoea, gastric haemorrhage, haematemesis, hepatic function abnormal, nausea (What is nausea?) on Jun 22, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, . Remodulin dosage: 56.16 Ug/kg (0.039 Ug/kg, 1 In 1 Min), Subcutaneous. Patient was hospitalized.

6798278-2 | Loss Of Consciousness, Pneumonia Viral
Adverse event was reported on Jun 14, 2010 by a Male patient taking Remodulin (View Usage) (Dosage: 172.8 Ug/kg (0.12 Ug/kg, 1 In 1 Min), Subcutaneous) . Location: UNITED STATES , 29 years of age, Patient had the following side effects: loss of consciousness, pneumonia viral. During the same period patient was treated with TRACLEER (BONSENTAN) (TABLETS) (View Tracleer (bonsentan) (tablets) Review and Tracleer (bonsentan) (tablets) Label ), REVATIO (SILDENAFIL CITRATE) (TABLETS) (View Revatio (sildenafil Citrate) (tablets) Review and Revatio (sildenafil Citrate) (tablets) Label ). Patient was hospitalized.

6798024-2 | Umbilical Hernia
on Jun 08, 2010 Female patient from UNITED STATES , 28 years of age, weighting 112.2 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: umbilical hernia. Remodulin dosage: 72 Ug/kg (0.05 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LETAIRIS (AMBRISENANT) (View Letairis (ambrisenant) Review and Letairis (ambrisenant) Label ), COUMADIN (View Coumadin Review and Coumadin Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

6798014-X | Infection
on Jun 14, 2010 Female patient from UNITED STATES , 30 years of age, weighting 169.8 lb, was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?). Remodulin dosage: 149.76 Ug/kg (0.104 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), REVATIO (View Revatio Review and Revatio Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PEPCID (View Pepcid Review and Pepcid Label ), PAXIL (View Paxil Review and Paxil Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), PROVENTIL (View Proventil Review and Proventil Label ), TRACELEER (BOSENTAN) (View Traceleer (bosentan) Review and Traceleer (bosentan) Label ). Patient was hospitalized.

6797979-X | Dehydration, Nausea
Patient was taking Remodulin (View Usage). Patient had the following side effects: dehydration, nausea (What is nausea?) on Jun 09, 2010 from UNITED STATES Additional patient health information: Female patient , 35 years of age, weighting 200.6 lb, . Remodulin dosage: 100.8 Ug/kg (0.07 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), LASIX (View Lasix Review and Lasix Label ), REVATIO (SILDENAFIL SODIUM) (View Revatio (sildenafil Sodium) Review and Revatio (sildenafil Sodium) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), MORPHINE (View Morphine Review and Morphine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6797419-0 |
Adverse event was reported on Jun 13, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: ) . Location: CANADA , 54 years of age, .

6773377-X | Device Related Infection, Jugular Vein Thrombosis, Staphylococcal Infection
on Jun 04, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: device related infection, jugular vein thrombosis, staphylococcal infection (What is staphylococcal infection?). Remodulin dosage: 47.52 Ug/kg (0.033 Ug/kg,1 In 1 Min),intravenous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), COUMADIN (View Coumadin Review and Coumadin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ). Patient was hospitalized.

6765955-9 | Pericardial Effusion, Pneumothorax
on Jun 01, 2010 Female patient from UNITED STATES , 54 years of age, weighting 249.1 lb, was treated with Remodulin (View Usage). Patient had the following side effects: pericardial effusion, pneumothorax. Remodulin dosage: 64.8 Ug/kg (0.045 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with VITAMIN B COMPLEX (B KOMPLEX) (View Vitamin B Complex (b-komplex) Review and Vitamin B Complex (b-komplex) Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), EVISTA (RALOXIFENE0 (View Evista (raloxifene0 Review and Evista (raloxifene0 Label ), REQUIP XL (View Requip Xl Review and Requip Xl Label ). Patient was hospitalized.

6763697-7 | Abdominal Distension
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: abdominal distension on May 26, 2010 from UNITED STATES Additional patient health information: Female patient , 28 years of age, weighting 112.2 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: 72 Ug/ Kg (0.05 Ug/kg, 1 In 1 Min, Subcutaneous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LETAIRIS(AMBRISENTAN) (View Letairis(ambrisentan) Review and Letairis(ambrisentan) Label ), COUMADIN (View Coumadin Review and Coumadin Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6750621-6 | Burning Sensation, Chest Pain, Device Malfunction, Dyspnoea, Lung Disorder
Adverse event was reported on May 18, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: CANADA , 15 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation, chest pain (What is chest pain?), device malfunction, dyspnoea, lung disorder. Patient was hospitalized.

6742771-5 | Abscess, Infection, Mass, Pain In Extremity, Poor Personal Hygiene, Pulmonary Hypertension, Treatment Noncompliance
on May 10, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: abscess (What is abscess?), infection (What is infection?), mass, pain in extremity, poor personal hygiene, pulmonary hypertension (What is pulmonary hypertension?), treatment noncompliance. Remodulin dosage: Subcutaneous. During the same period patient was treated with KLOR CON (View Klor-con Review and Klor-con Label ), ISOSORB MONO (ISOSORBIDE DINITRATE) (View Isosorb Mono (isosorbide Dinitrate) Review and Isosorb Mono (isosorbide Dinitrate) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROVIGIL (View Provigil Review and Provigil Label ), MAGNEBIND (GALENIC/MAGNESIUM CARB/CALCIUM CARB/) (View Magnebind (galenic/magnesium Carb/calcium Carb/) Review and Magnebind (galenic/magnesium Carb/calcium Carb/) Label ). Patient was hospitalized.

6724706-4 | Hyperthermia, Hypotension, Lower Respiratory Tract Infection, Oxygen Saturation Decreased
on May 03, 2010 Female patient from UNITED STATES , 56 years of age, weighting 175.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: hyperthermia, hypotension, lower respiratory tract infection, oxygen saturation decreased. Remodulin dosage: 40.32 Ug/kg (0.028 Ug/kg, 1 In 1 Min) Intravenous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), HYDROXLYCHLOROQUINE (View Hydroxlychloroquine Review and Hydroxlychloroquine Label ), AGGRENOX (View Aggrenox Review and Aggrenox Label ), TRACLEER (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6719432-1 | Dehydration, Diarrhoea, Dizziness
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, dizziness (What is dizziness?) on Apr 03, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: 92.16 Ug/kg (0.064 Ug/kg, 1 In 1 Min) Subcutaneous. During the same period patient was treated with BOSENTAN (BOSENTAN) (125 MILLIGRAM, TABLETS) (250mg (125 Mg, 2 In 1 D), Oral) (View Bosentan (bosentan) (125 Milligram, Tablets) Review and Bosentan (bosentan) (125 Milligram, Tablets) Label ), SILDENAFIL (SINLDENAFIL) (View Sildenafil (sinldenafil) Review and Sildenafil (sinldenafil) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PROTONIX (View Protonix Review and Protonix Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6718721-4 | Cardiac Failure
Adverse event was reported on Apr 23, 2010 by a Male patient taking Remodulin (View Usage) (Dosage: 33.12 Ug/kg (0.023 Ug/kg, 1 In 1 Min), Subuctaneous) was diagnosed with pulmonary arterial hypertension and. Location: AUSTRIA , 85 years of age, weighting 187.2 lb, Patient had the following side effects: cardiac failure. During the same period patient was treated with AVODART (DUTASTERIDE) (CAPSULES) (View Avodart (dutasteride) (capsules) Review and Avodart (dutasteride) (capsules) Label ), ALNA (TAMSULOSIN HYDROCHLORIDE) (CAPSULES) (View Alna (tamsulosin Hydrochloride) (capsules) Review and Alna (tamsulosin Hydrochloride) (capsules) Label ), PANTOLOC (PANTOPRAZOLE) (TABLETS) (View Pantoloc (pantoprazole) (tablets) Review and Pantoloc (pantoprazole) (tablets) Label ), SPIRONO (SPIRONOLACTONE) (View Spirono (spironolactone) Review and Spirono (spironolactone) Label ), SEDACORON (AMIODARONE HYDROCHLORIDE) (TABLETS) (View Sedacoron (amiodarone Hydrochloride) (tablets) Review and Sedacoron (amiodarone Hydrochloride) (tablets) Label ), AQUAPHORIL (IXPAMIDE) (TABLETS) (View Aquaphoril (ixpamide) (tablets) Review and Aquaphoril (ixpamide) (tablets) Label ), LASIX (View Lasix Review and Lasix Label ), MARCOUMAR (PHENPROCOUMON) (TABLETS) (View Marcoumar (phenprocoumon) (tablets) Review and Marcoumar (phenprocoumon) (tablets) Label ). Patient was hospitalized.

6706000-0 | Anxiety, Ascites, Hypertension, Oedema, Right Ventricular Failure, Tachycardia
on Apr 19, 2010 Female patient from UNITED STATES , 66 years of age, weighting 190.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: anxiety (What is anxiety?), ascites, hypertension, oedema, right ventricular failure, tachycardia. Remodulin dosage: 135.36 Ug/kg(0.094 Ug/kg, 1 In 1 Min Intravenous. During the same period patient was treated with REVATIO (40 Mg) (View Revatio Review and Revatio Label ), AMBRISENTAN (AMBRISENTAN) (10 Mg (10 Mg, 1 In 1d)) (View Ambrisentan (ambrisentan) Review and Ambrisentan (ambrisentan) Label ), POTASSIUM CHLORIDE (40 Milliequivalents (20, Milliequivalents, 2 In 1 D)) (View Potassium Chloride Review and Potassium Chloride Label ), LASIX (View Lasix Review and Lasix Label ), PREMARIN (View Premarin Review and Premarin Label ), NEXIUM (View Nexium Review and Nexium Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ), CLARITIN (View Claritin Review and Claritin Label ).

6700735-1 | Diarrhoea, Hypophagia, Nausea, Pain
on Apr 10, 2010 Male patient from AUSTRIA , 76 years of age, weighting 121.3 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hypophagia, nausea (What is nausea?), pain (What is pain?). Remodulin dosage: 57.6 Ug/kg(0.04 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HCT (HYDROCHLOROTHIAIZDE) (View Hct (hydrochlorothiaizde) Review and Hct (hydrochlorothiaizde) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6700712-0 | Blood Pressure Decreased, Injection Site Erythema, Injection Site Pain, Local Swelling, Pneumonia, Refusal Of Treatment By Patient
Patient was taking Remodulin (View Usage). Patient had the following side effects: blood pressure decreased, injection site erythema, injection site pain, local swelling, pneumonia (What is pneumonia?), refusal of treatment by patient on Apr 15, 2010 from AUSTRIA Additional patient health information: Female patient , 64 years of age, weighting 136.7 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: 10.8 Ug/kg (0.0075 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), REVATIO (View Revatio Review and Revatio Label ), LASIX (View Lasix Review and Lasix Label ), SERETIDE (View Seretide Review and Seretide Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), SINTROM (View Sintrom Review and Sintrom Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6700711-9 | Cardiac Failure, Dermatitis Exfoliative
Adverse event was reported on Apr 13, 2010 by a Male patient taking Remodulin (View Usage) (Dosage: 768 Ul (32 Ul, 1 In 1 Hr)) . Location: AUSTRIA , weighting 178.1 lb, After Remodulin was administered, patient had the following side effects: cardiac failure, dermatitis exfoliative. During the same period patient was treated with AVODART (View Avodart Review and Avodart Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), PANTOLIC (PANTOPRAZOLE) (View Pantolic (pantoprazole) Review and Pantolic (pantoprazole) Label ), SPIRONO (SPIRONOLACTONE) (View Spirono (spironolactone) Review and Spirono (spironolactone) Label ), SEDACORON (AMIODARONE HYDROCHLORIDE) (View Sedacoron (amiodarone Hydrochloride) Review and Sedacoron (amiodarone Hydrochloride) Label ), AQUAPHORIL (XIPAMIDE) (View Aquaphoril (xipamide) Review and Aquaphoril (xipamide) Label ), LASIX (View Lasix Review and Lasix Label ), MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6699428-9 | Disease Progression, Dizziness, Head Injury, Hypotension, Oxygen Saturation Decreased, Pulmonary Arterial Hypertension, Right Ventricular Failure, Syncope
on Apr 13, 2010 Female patient from UNITED STATES , 73 years of age, weighting 145.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, dizziness (What is dizziness?), head injury, hypotension, oxygen saturation decreased, pulmonary arterial hypertension, right ventricular failure, syncope. Remodulin dosage: 60.84 Ug/kg (0.04225 Ug/kg,1 In 1 Min), Subcutaneous. During the same period patient was treated with TYVASO (Inhalation) (View Tyvaso Review and Tyvaso Label ), SINGULAIR (View Singulair Review and Singulair Label ), COUMADIN (View Coumadin Review and Coumadin Label ), REVATIO (SILDENAFIL CITRATE) (TABLETS) (View Revatio (sildenafil Citrate) (tablets) Review and Revatio (sildenafil Citrate) (tablets) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), KLOR CON (POTASSIUM CHLORIDE) (TABLETS) (View Klor-con (potassium Chloride) (tablets) Review and Klor-con (potassium Chloride) (tablets) Label ), DILTIA XT (DILTIAZEM HYDROCHLORIDE) (CAPSULES) (View Diltia Xt (diltiazem Hydrochloride) (capsules) Review and Diltia Xt (diltiazem Hydrochloride) (capsules) Label ).

6699427-7 | Atrial Flutter
on Apr 15, 2010 Female patient from UNITED STATES , 68 years of age, weighting 180.3 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: atrial flutter. Remodulin dosage: 152.64 Ug/kg (0.106 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VIAGRA (View Viagra Review and Viagra Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6687294-7 | Atrial Flutter
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: atrial flutter on Apr 06, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 180.3 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 152.64 Ug/kg (0.106 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CELEBREX (View Celebrex Review and Celebrex Label ), LASIX (View Lasix Review and Lasix Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VIAGRA (View Viagra Review and Viagra Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6686062-X | Decreased Appetite, Diarrhoea, Nausea, Pain
Adverse event was reported on Apr 03, 2010 by a Male patient taking Remodulin (View Usage) (Dosage: 57.6 Ug/kg (0.04 Ug/kg,1 In 1 Min),subcutaneous) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: AUSTRIA , weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: decreased appetite, diarrhoea, nausea (What is nausea?), pain (What is pain?). During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6680372-8 | Oxygen Saturation Decreased
on Mar 29, 2010 Female patient from UNITED STATES , 38 years of age, weighting 175.0 lb, was treated with Remodulin (View Usage). Patient had the following side effects: oxygen saturation decreased. Remodulin dosage: 59.04 Ug/kg (0.041 Ug/kg, 1 In 1 Min), Subcutaneous. Patient was hospitalized.

6673772-3 | Catheter Site Infection, Pneumonia
on Mar 26, 2010 Male patient from UNITED STATES , child 10 years of age, weighting 66.14 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: catheter site infection, pneumonia (What is pneumonia?). Remodulin dosage: 95.04 Ug/kg (0.066 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6659919-3 | Hypokalaemia, Right Ventricular Dysfunction, Syncope
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, right ventricular dysfunction, syncope on Mar 15, 2010 from SLOVAKIA (Slovak Republic) Additional patient health information: Male patient , 55 years of age, weighting 180.8 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 17.28 Ug/kg (0.012 Ug/kg, 1 In 1 Min), Subcutaneous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), REVATIO (View Revatio Review and Revatio Label ), INSPRA (View Inspra Review and Inspra Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6645972-X | Condition Aggravated, Diarrhoea, Eye Infection Staphylococcal, Oedema, Pneumonia, Pulmonary Arterial Hypertension
Adverse event was reported on Mar 09, 2010 by a Female patient taking Remodulin (View Usage) (Dosage: 72 Ug/kg (0.05 Ug/kg,1 In 1 Min),intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 44 years of age, Patient had the following side effects: condition aggravated, diarrhoea, eye infection staphylococcal, oedema, pneumonia (What is pneumonia?), pulmonary arterial hypertension. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), COUMADIN (WARARIN SODIUM) (View Coumadin (wararin Sodium) Review and Coumadin (wararin Sodium) Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), DIURETICS (DIURETICS) (View Diuretics (diuretics) Review and Diuretics (diuretics) Label ), LOMOTIL (LOMOTIL /00034001/) (View Lomotil (lomotil /00034001/) Review and Lomotil (lomotil /00034001/) Label ). Patient was hospitalized.

6632639-7 | Dizziness, Head Injury, Hypotension, Oxygen Saturation Decreased, Respiratory Failure, Syncope
on Feb 26, 2010 Female patient from UNITED STATES , 73 years of age, weighting 145.9 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: dizziness (What is dizziness?), head injury, hypotension, oxygen saturation decreased, respiratory failure, syncope. Remodulin dosage: 60.84 Ug/kg (0.04225 Ug/ke,1 In 1 Min) Subcutaneous. During the same period patient was treated with TYVASO (Inhalation) (View Tyvaso Review and Tyvaso Label ), SINGULAIR (View Singulair Review and Singulair Label ), COUMANDIN (WARFARIN SODIUM) (TABLIETS) (View Coumandin (warfarin Sodium) (tabliets) Review and Coumandin (warfarin Sodium) (tabliets) Label ), REVATIO (SILDENAFIL CITRATE) (TABLETS) (View Revatio (sildenafil Citrate) (tablets) Review and Revatio (sildenafil Citrate) (tablets) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), KLOR CON (POTASSIUM CHLORIDE) (TABLETS) (View Klor-con (potassium Chloride) (tablets) Review and Klor-con (potassium Chloride) (tablets) Label ), DILTIA XT (DILTIAZEM HYDROCHLORIDE) (CAPSULES) (View Diltia Xt (diltiazem Hydrochloride) (capsules) Review and Diltia Xt (diltiazem Hydrochloride) (capsules) Label ).

6614949-2 | Chest Pain, Device Malfunction, Dyspnoea, Incorrect Dose Administered, Lung Disorder, Malaise
on Jan 19, 2010 Female patient from CANADA , 15 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), device malfunction, dyspnoea, incorrect dose administered, lung disorder, malaise. Remodulin dosage: . Patient was hospitalized.

6551317-6 | Haematoma, Infection
Patient was taking Remodulin (View Usage). Patient had the following side effects: haematoma, infection (What is infection?) on Dec 01, 2009 from AUSTRIA Additional patient health information: Female patient , weighting 231.5 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: (0.01375 Ug/kg,delivered Via Cadd Ms3 Pump), Subcutaneous. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), TRACLEER (View Tracleer Review and Tracleer Label ), LASIX (View Lasix Review and Lasix Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), TRESLEEN (SERTRALINE) (View Tresleen (sertraline) Review and Tresleen (sertraline) Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ). Patient was hospitalized.

6472478-3 | Haematoma Infection, Injection Site Haematoma
Adverse event was reported on Nov 15, 2009 by a Female patient taking Remodulin (View Usage) (Dosage: (0.01375 Ug/kg)) . Location: AUSTRIA , 70 years of age, weighting 231.5 lb, After Remodulin was administered, patient had the following side effects: haematoma infection, injection site haematoma. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), TRACLEER (View Tracleer Review and Tracleer Label ), LASIX (View Lasix Review and Lasix Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), TRESLEEN (SERTRALINE) (View Tresleen (sertraline) Review and Tresleen (sertraline) Label ), TRITTICO (TRAZADONE HYDROCHLORIDE) (View Trittico (trazadone Hydrochloride) Review and Trittico (trazadone Hydrochloride) Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ). Patient was hospitalized.

6443269-4 | Endocarditis Pseudomonal, Sepsis
on Nov 03, 2009 Male patient from UNITED STATES , 19 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: endocarditis pseudomonal, sepsis (What is sepsis?). Remodulin dosage: 86.4 Ug/kg (0.06 Ug/kg, 1 In 1 Min), Intravenous. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), FLOVENT (View Flovent Review and Flovent Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6429312-7 | Myocardial Infarction
on Oct 19, 2009 Female patient from UNITED STATES , weighting 271.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: myocardial infarction. Remodulin dosage: 0.0042 Ug/kg, 1 In 1 Min), Subcutaneous. Patient was hospitalized.

6415827-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bacteraemia, Blood Alkaline Phosphatase Increased, Blood Culture Positive, Brain Herniation, Culture Urine Positive, Dizziness, Dysstasia
Patient was taking Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteraemia, blood alkaline phosphatase increased, blood culture positive, brain herniation, culture urine positive, dizziness (What is dizziness?), dysstasia on Oct 12, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 133.2 lb, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: 0.00625 Ug/kg, 1 In 1 Min); Intravenous, 0.005 Ug/kg, 1 In 1 Min); Intravenous. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), REVATIO (View Revatio Review and Revatio Label ), LETAIRIS (AMBRISENTAN) (View Letairis (ambrisentan) Review and Letairis (ambrisentan) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6389021-X | Device Related Infection, Ear Infection, Influenza Like Illness, Pneumonia
Adverse event was reported on Mar 07, 2008 by a Female patient taking Remodulin (View Usage) (Dosage: 220.32 Ug/kg (0.153 Ug/kg, 1 In 1 Min), Intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 55 years of age, Patient experienced the following unwanted or unexpected effects: device related infection, ear infection (What is ear infection?), influenza like illness, pneumonia (What is pneumonia?). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PROCARDIA (View Procardia Review and Procardia Label ), HUMIRA (View Humira Review and Humira Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6384421-6 | Cardiac Aneurysm, Coronary Artery Occlusion, Ejection Fraction Decreased, Myocardial Infarction
on Sep 21, 2009 Male patient from CZECH REPUBLIC , 56 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Remodulin (View Usage). Patient had the following side effects: cardiac aneurysm, coronary artery occlusion, ejection fraction decreased, myocardial infarction. Remodulin dosage: 21.6 Ug/kg (0.015 Ug/kg,1 In 1 Min). During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), BETALOC (METOPROLOL TARTRATE) (View Betaloc (metoprolol Tartrate) Review and Betaloc (metoprolol Tartrate) Label ), HELICID (OMEPRAZOLE) (View Helicid (omeprazole) Review and Helicid (omeprazole) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VEROAPIRON (SPIRONOLACTONE) (View Veroapiron (spironolactone) Review and Veroapiron (spironolactone) Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), MILURID (View Milurid Review and Milurid Label ), INZULIN (INSULIN) (View Inzulin (insulin) Review and Inzulin (insulin) Label ). Patient was hospitalized.

6357970-4 | Coronary Artery Aneurysm, Coronary Artery Occlusion, Coronary Artery Thrombosis, Ejection Fraction Decreased, Myocardial Infarction
on Aug 26, 2009 Male patient from CZECH REPUBLIC , 58 years of age, was diagnosed with pulmonary artery wall hypertrophy and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: coronary artery aneurysm, coronary artery occlusion, coronary artery thrombosis, ejection fraction decreased, myocardial infarction. Remodulin dosage: 15 Mg (15 Mg,1 In 1 D). During the same period patient was treated with SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ). Patient was hospitalized.

6355509-0 | Endocarditis Bacterial
Patient was taking Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: endocarditis bacterial on Aug 25, 2009 from UNITED STATES Additional patient health information: Male patient , 19 years of age, was diagnosed with pulmonary arterial hypertension and. Remodulin dosage: Intravenous. Patient was hospitalized.

6299781-4 | Cardiac Arrest, Circulatory Collapse, Haemoglobin Decreased, Polycythaemia, Pulmonary Arterial Hypertension, Unresponsive To Stimuli
Adverse event was reported on Jul 24, 2009 by a Male patient taking Remodulin (View Usage) (Dosage: 43.2 Ug/kg (0.03 Ug/kg, 1 In 1 Min), Intravenous) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 36 years of age, weighting 179.9 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), circulatory collapse, haemoglobin decreased, polycythaemia, pulmonary arterial hypertension, unresponsive to stimuli. During the same period patient was treated with REVATIO (SILDENAFIL CITRATE) (TABLETS) (View Revatio (sildenafil Citrate) (tablets) Review and Revatio (sildenafil Citrate) (tablets) Label ), FUROSEMIDE (FUROSEMIDE) (TABLETS) (View Furosemide (furosemide) (tablets) Review and Furosemide (furosemide) (tablets) Label ), LETAIRIS (View Letairis Review and Letairis Label ), COUMADIN (View Coumadin Review and Coumadin Label ), PROTONIX (View Protonix Review and Protonix Label ), FISH OIL (FISH OIL) (CAPSULES) (View Fish Oil (fish Oil) (capsules) Review and Fish Oil (fish Oil) (capsules) Label ), ACETAMINOPHEN (PARACETAMOL) (TABLETS) (View Acetaminophen (paracetamol) (tablets) Review and Acetaminophen (paracetamol) (tablets) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6210715-0 | Injection Site Cellulitis
on May 28, 2009 Male patient from UNITED STATES , weighting 201.9 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). After Remodulin was administered, patient had the following side effects: injection site cellulitis. Remodulin dosage: 128ng/kg/min Continuous Prior To Admission. Patient was hospitalized.

6141729-7 | Culture Positive, Diarrhoea, Influenza Like Illness, Injection Site Abscess, Nausea, Oxygen Saturation Decreased, Staphylococcal Infection, Systemic Inflammatory Response Syndrome
on Mar 31, 2009 Female patient from UNITED STATES , 54 years of age, weighting 160.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Remodulin (View Usage). Patient experienced the following unwanted or unexpected effects: culture positive, diarrhoea, influenza like illness, injection site abscess, nausea (What is nausea?), oxygen saturation decreased, staphylococcal infection (What is staphylococcal infection?), systemic inflammatory response syndrome. Remodulin dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), WARFARIN (View Warfarin Review and Warfarin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), DARVOCET (View Darvocet Review and Darvocet Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6112315-X | Abdominal Distension, Asthenia, Back Pain, Chest Pain, Cyanosis, Diarrhoea, Dyspnoea, Erythema
Patient was taking Remodulin (View Usage). Patient had the following side effects: abdominal distension, asthenia, back pain (What is back pain?), chest pain (What is chest pain?), cyanosis, diarrhoea, dyspnoea, erythema on Mar 11, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 128.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Remodulin dosage: Dosage Was Progressive Pump Subq. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ).